TY - JOUR AU - Herman, G. A. AU - Stein, P. P. AU - Thornberry, N. A. AU - Wagner, J. A. PY - 2007 DA - 2007// TI - Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin JO - Clin Pharmacol Ther VL - 81 UR - https://doi.org/10.1038/sj.clpt.6100167 DO - 10.1038/sj.clpt.6100167 ID - Herman2007 ER - TY - JOUR AU - Herman, G. A. AU - Stevens, C. AU - Van Dyck, K. AU - Bergman, A. AU - Yi, B. AU - De Smet, M. PY - 2005 DA - 2005// TI - Pharmacokinetics and pharmacodynamics of single doses of sitagliptin, an inhibitor of dipeptidyl peptidase-IV, in healthy subjects JO - Clin Pharm Therap VL - 78 UR - https://doi.org/10.1016/j.clpt.2005.09.002 DO - 10.1016/j.clpt.2005.09.002 ID - Herman2005 ER - TY - JOUR AU - Drucker, D. J. AU - Nauck, M. A. PY - 2006 DA - 2006// TI - GLP-1R agonists (incretin mimetics) and DPP-4 inhibitors (incretin enhancers) for the treatment of type 2 diabetes JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69705-5 DO - 10.1016/S0140-6736(06)69705-5 ID - Drucker2006 ER - TY - JOUR AU - Aschner, P. AU - Kipnes, M. S. AU - Lunceford, J. K. AU - Sanchez, M. AU - Mickel, C. AU - Williams-Herman, D. E. PY - 2006 DA - 2006// TI - Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc06-0703 DO - 10.2337/dc06-0703 ID - Aschner2006 ER - TY - JOUR AU - Raz, I. AU - Hanefeld, M. AU - Xu, L. AU - Caria, C. AU - Williams-Herman, D. AU - Khatami, H. PY - 2006 DA - 2006// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus JO - Diabetologia VL - 49 UR - https://doi.org/10.1007/s00125-006-0416-z DO - 10.1007/s00125-006-0416-z ID - Raz2006 ER - TY - JOUR AU - Scott, R. AU - Wu, M. AU - Sanchez, M. AU - Stein, P. P. PY - 2007 DA - 2007// TI - Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes JO - Int J Clin Pract VL - 61 UR - https://doi.org/10.1111/j.1742-1241.2006.01246.x DO - 10.1111/j.1742-1241.2006.01246.x ID - Scott2007 ER - TY - JOUR AU - Nonaka, K. AU - Kakikawa, T. AU - Sato, A. AU - Okuyama, K. AU - Fujimoto, G. AU - Kato, N. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes JO - Diabetes Res Clin Pract VL - 79 UR - https://doi.org/10.1016/j.diabres.2007.08.021 DO - 10.1016/j.diabres.2007.08.021 ID - Nonaka2008 ER - TY - JOUR AU - Hanefeld, M. AU - Herman, G. A. AU - Wu, M. AU - Mickel, C. AU - Sanchez, M. AU - Stein, P. P. PY - 2007 DA - 2007// TI - Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X188152 DO - 10.1185/030079907X188152 ID - Hanefeld2007 ER - TY - JOUR AU - Charbonnel, B. AU - Karasik, A. AU - Liu, J. AU - Wu, M. AU - Meininger, G. PY - 2006 DA - 2006// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled on metformin alone JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc06-0706 DO - 10.2337/dc06-0706 ID - Charbonnel2006 ER - TY - JOUR AU - Hermansen, K. AU - Kipnes, M. AU - Luo, E. AU - Fanurik, D. AU - Khatami, H. AU - Stein, P. PY - 2007 DA - 2007// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2007.00744.x DO - 10.1111/j.1463-1326.2007.00744.x ID - Hermansen2007 ER - TY - JOUR AU - Rosenstock, J. AU - Brazg, R. AU - Andryuk, P. J. AU - Lu, K. AU - Stein, P. P. PY - 2006 DA - 2006// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-Blind, placebo-controlled parallel group study JO - Clin Ther VL - 28 UR - https://doi.org/10.1016/j.clinthera.2006.10.007 DO - 10.1016/j.clinthera.2006.10.007 ID - Rosenstock2006 ER - TY - JOUR AU - Goldstein, B. J. AU - Feinglos, M. N. AU - Lunceford, J. K. AU - Johnson, J. AU - Williams-Herman, D. E. PY - 2007 DA - 2007// TI - Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc07-0627 DO - 10.2337/dc07-0627 ID - Goldstein2007 ER - TY - JOUR AU - Raz, I. AU - Chen, Y. AU - Wu, M. AU - Hussain, S. AU - Kaufman, K. D. AU - Amatruda, J. M. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/030079908X260925 DO - 10.1185/030079908X260925 ID - Raz2008 ER - TY - JOUR AU - Nauck, M. A. AU - Meininger, G. AU - Sheng, D. AU - Terranella, L. AU - Stein, P. P. PY - 2007 DA - 2007// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2006.00704.x DO - 10.1111/j.1463-1326.2006.00704.x ID - Nauck2007 ER - TY - JOUR AU - Chan, J. C. N. AU - Scott, R. AU - Arjona-Ferreira, J. C. AU - Sheng, D. AU - Gonzalez, E. AU - Davies, M. J. PY - 2008 DA - 2008// TI - Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00914.x DO - 10.1111/j.1463-1326.2008.00914.x ID - Chan2008 ER - TY - CHAP PY - 2007 DA - 2007// BT - JANUVIA (sitagliptin) PB - Co., Inc CY - Whitehouse Station, NJ ID - ref16 ER - TY - JOUR AU - Newcombe, R. G. PY - 1998 DA - 1998// TI - Interval estimation for the difference between independent proportions: comparison of eleven methods JO - Stat Med VL - 17 UR - https://doi.org/3.0.CO;2-I DO - 3.0.CO;2-I ID - Newcombe1998 ER - TY - JOUR AU - Herman, G. A. AU - Bergman, A. AU - Stevens, C. AU - Kotey, P. AU - Yi, B. AU - Zhao, P. L. PY - 2006 DA - 2006// TI - Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels following an oral glucose tolerance test in patients with type 2 diabetes JO - J Clin Endocrinol Metab VL - 91 UR - https://doi.org/10.1210/jc.2006-1009 DO - 10.1210/jc.2006-1009 ID - Herman2006 ER - TY - JOUR AU - Denker, P. S. AU - Dimarco, P. E. PY - 2006 DA - 2006// TI - Exenatide (exendin-4)-induced pancreatitis: a case report JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/diacare.29.02.06.dc05-2043 DO - 10.2337/diacare.29.02.06.dc05-2043 ID - Denker2006 ER - TY - JOUR AU - Ahmad, S. R. AU - Swann, J. PY - 2008 DA - 2008// TI - Exenatide and rare adverse events JO - N Engl J Med VL - 358 ID - Ahmad2008 ER - TY - JOUR AU - Gorrell, M. D. AU - Gysbers, V. AU - McCaughan, G. W. PY - 2001 DA - 2001// TI - CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes JO - Scand J Immunol VL - 54 UR - https://doi.org/10.1046/j.1365-3083.2001.00984.x DO - 10.1046/j.1365-3083.2001.00984.x ID - Gorrell2001 ER - TY - JOUR AU - Boonacker, E. P. AU - Wierenga, E. A. AU - Smits, H. H. AU - Van Noorden, C. J. PY - 2002 DA - 2002// TI - CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry JO - J Histochem Cytochem VL - 50 UR - https://doi.org/10.1177/002215540205000903 DO - 10.1177/002215540205000903 ID - Boonacker2002 ER - TY - JOUR AU - Marguet, D. AU - Baggio, L. AU - Kobayashi, T. AU - Bernard, A. M. AU - Pierres, M. AU - Nielsen, P. F. PY - 2000 DA - 2000// TI - Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.120069197 DO - 10.1073/pnas.120069197 ID - Marguet2000 ER - TY - JOUR AU - Lankas, G. R. AU - Leiting, B. AU - Roy, R. S. AU - Eiermann, G. J. AU - Beconi, M. G. AU - Biftu, T. PY - 2005 DA - 2005// TI - Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 JO - Diabetes VL - 54 UR - https://doi.org/10.2337/diabetes.54.10.2988 DO - 10.2337/diabetes.54.10.2988 ID - Lankas2005 ER - TY - STD TI - Vora KA, Porter G, Peng R, Cui Y, Eiermann G, Zaller DM: Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact the ability to mount T cell-dependent immune responses. Diabetes. ID - ref25 ER - TY - STD TI - European Medicines Agency (EMEA): Galvus (vildagliptin) – European Public Assessment Report (EPAR) – Scientific Discussion. 7-[http://www.emea.europa.eu/humandocs/PDFs/EPAR/galvus/H-771-en6.pdf] UR - http://www.emea.europa.eu/humandocs/PDFs/EPAR/galvus/H-771-en6.pdf ID - ref26 ER - TY - STD TI - Phenomix Corp: Securities Registration Statement (S-1) – Risk Factors. 9-[http://sec.edgar-online.com/2008/01/25/0001193125-08-012530/Section8.asp] UR - http://sec.edgar-online.com/2008/01/25/0001193125-08-012530/Section8.asp ID - ref27 ER - TY - STD TI - FDA – CDER: Januvia (sitagliptin phosphate): Application Number 21-995 – Medical Review. 23-[http://www.fda.gov/cder/foi/nda/2006/021995s000_MedR.pdf] UR - http://www.fda.gov/cder/foi/nda/2006/021995s000_MedR.pdf ID - ref28 ER - TY - JOUR AU - Byrd, J. B. AU - Touzin, K. AU - Sile, S. AU - Gainer, J. V. AU - Yu, C. AU - Nadeau, J. PY - 2008 DA - 2008// TI - Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema JO - Hypertension VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.096552 DO - 10.1161/HYPERTENSIONAHA.107.096552 ID - Byrd2008 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Ronnemaa, T. AU - Pyorala, K. AU - Laakso, M. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR AU - Nauck, M. A. AU - Kleine, N. AU - Orskov, C. AU - Holst, J. J. AU - Willms, B. AU - Creutzfeldt, W. PY - 1993 DA - 1993// TI - Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7–36 amide) in type 2 (non-insulin-dependent) diabetic patients JO - Diabetologia VL - 36 UR - https://doi.org/10.1007/BF00401145 DO - 10.1007/BF00401145 ID - Nauck1993 ER - TY - JOUR AU - Buse, J. B. AU - Henry, R. R. AU - Han, J. AU - Kim, D. D. AU - Fineman, M. S. AU - Baron, A. D. PY - 2004 DA - 2004// TI - Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.11.2628 DO - 10.2337/diacare.27.11.2628 ID - Buse2004 ER - TY - JOUR AU - Roberts, V. L. AU - Stewart, J. AU - Issa, M. AU - Lake, B. AU - Melis, R. PY - 2005 DA - 2005// TI - Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study JO - Clin Ther VL - 27 UR - https://doi.org/10.1016/j.clinthera.2005.10.017 DO - 10.1016/j.clinthera.2005.10.017 ID - Roberts2005 ER - TY - JOUR AU - Lewin, A. AU - Lipetz, R. AU - Wu, J. AU - Schwartz, S. PY - 2007 DA - 2007// TI - Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.05.013 DO - 10.1016/j.clinthera.2007.05.013 ID - Lewin2007 ER - TY - JOUR AU - Inzucchi, S. E. PY - 2002 DA - 2002// TI - Oral antihyperglycemic therapy for type 2 diabetes: scientific review JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.3.360 DO - 10.1001/jama.287.3.360 ID - Inzucchi2002 ER - TY - JOUR AU - Conarello, S. L. AU - Li, Z. AU - Ronan, J. AU - Roy, R. S. AU - Zhu, L. AU - Jiang, G. PY - 2003 DA - 2003// TI - Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance JO - Proc Natl Acad Sci USA VL - 100 UR - https://doi.org/10.1073/pnas.0631828100 DO - 10.1073/pnas.0631828100 ID - Conarello2003 ER - TY - JOUR AU - Amori, R. E. AU - Lau, J. AU - Pittas, A. G. PY - 2007 DA - 2007// TI - Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.2.194 DO - 10.1001/jama.298.2.194 ID - Amori2007 ER - TY - JOUR AU - Byrd, J. B. AU - Shreevatsa, A. AU - Putlur, P. AU - Foretia, D. AU - McAlexander, L. AU - Sinha, T. PY - 2007 DA - 2007// TI - Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema JO - J Allergy Clin Immunol VL - 120 UR - https://doi.org/10.1016/j.jaci.2007.04.012 DO - 10.1016/j.jaci.2007.04.012 ID - Byrd2007 ER - TY - JOUR AU - Yang, W. AU - Mohan, V. AU - Son, H. Y. AU - Liu, J. AU - Langdon, R. B. AU - Stein, P. PY - 2007 DA - 2007// TI - Sitagliptin monotherapy significantly improves glycemic control and beta-cell function, and is well tolerated in patients with type 2 diabetes in China, India, and Korea (abstract) JO - ASEAN Federation of Endocrine Societies VL - 24 ID - Yang2007 ER - TY - JOUR AU - Dobs, A. AU - Goldstein, B. J. AU - Wieczorek, L. AU - Golm, G. AU - Davies, M. J. AU - Williams-Herman, D. PY - 2008 DA - 2008// TI - Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycemic control in patients with type 2 diabetes (abstract) JO - Diabetes VL - 57 ID - Dobs2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/8/14/prepub UR - http://www.biomedcentral.com/1472-6823/8/14/prepub ID - ref41 ER -